《Molecular Therapy-methods & Clinical Development》重点专注发布Biochemistry, Genetics and Molecular Biology-Molecular Biology领域的新研究，旨在促进和传播该领域相关的新技术和新知识。鼓励该领域研究者详细地发表他们的高质量实验研究和理论结果。根据网友分享的投稿经验，平均审稿速度为 12 Weeks 。该杂志创刊至今，在Biochemistry, Genetics and Molecular Biology-Molecular Biology领域，影响力非凡，对来稿文章质量要求很高，稿件投稿过审难度很大，刊登文章的学术水平和编辑质量在同类杂志中均名列前茅。如果你想在该杂志上发表论文，你可以向编辑部提交文章，但文章必须具有重要意义并代表该领域专业的发展。我们欢迎广大同领域的研究者提交投稿。
| CiteScore | SJR | SNIP | CiteScore排名 | |||
|---|---|---|---|---|---|---|
| 9.9 | 1.896 | 1.076 | 学科类别 | 分区 | 排名 | 百分位 |
|
大类：大类：Biochemistry,GeneticsandMolecularBiology
小类：小类：Genetics
|
Q1 | 43/347 | 87% | |||
|
大类：大类：Biochemistry,GeneticsandMolecularBiology
小类：小类：MolecularBiology
|
Q1 | 75/410 | 81% | |||
|
大类：大类：Biochemistry,GeneticsandMolecularBiology
小类：小类：MolecularMedicine
|
Q1 | 36/178 | 80% | |||
| 按JIF指标学科分区 | 收录子集 | 分区 | 排名 | 百分位 |
|---|---|---|---|---|
| 学科：MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q2 | 54 / 136 | 60.7% |
文章名称
引用次数
Emerging Issues in AAV-Mediated In Vivo Gene Therapy
115
Engineering and Design of Chimeric Antigen Receptors
48
Capsid Modifications for Targeting and Improving the Efficacy of AAV Vectors
45
Prevalence of Pre-existing Antibodies to CRISPR-Associated Nuclease Cas9 in the USA Population
37
Influence of Pre-existing Anti-capsid Neutralizing and Binding Antibodies on AAV Vector Transduction
31
Engineering Nanoparticles for Targeted Delivery of Nucleic Acid Therapeutics in Tumor
30
Improved Loading of Plasma-Derived Extracellular Vesicles to Encapsulate Antitumor miRNAs
30
Gene Transfer with AAV9-PHP.B Rescues Hearing in a Mouse Model of Usher Syndrome 3A and Transduces Hair Cells in a Non-human Primate
26
Pharmacology of Recombinant Adeno-associated Virus Production
23
EU Regulatory Pathways for ATMPs: Standard, Accelerated and Adaptive Pathways to Marketing Authorisation
23
国家/地区
发文量
TUSA
279
TCHINA MAINLAND
61
TEngland
54
TFrance
50
TGERMANY (FED REP GER)
39
TJapan
32
TItaly
29
TNetherlands
25
TCanada
22
TSouth Korea
16
